Esab CORP

Market Movers (8-K)

NYSE
ESAB Corporation appoints Mitchell P. Rales as Executive Chair and grants performance-based stock options to leadership.
NYSE
ESAB Corporation announced the completion of its acquisition of Eddyfi Technologies for $1.45 billion, financed through cash, senior notes, and preferred stock.
Capital raise
NYSE
ESAB Corporation announced the results of its 2026 Annual Meeting of Stockholders, including the election of nine directors and the ratification of its independent auditor.
NYSE
ESAB Corporation reported record first quarter 2026 sales of $746 million, a 10% increase year-over-year, driven by acquisitions, while core organic sales decreased by 1%.
Capital raise
NYSE
ESAB Corporation announced the appointment of R. Brent Jones as its new Chief Financial Officer, effective early May 2026, while also reaffirming its 2026 financial outlook.
NYSE
ESAB Corporation issued $1 billion in 5.625% senior notes due 2031 to partially fund the $1.45 billion acquisition of Eddyfi Technologies.
Delay expected
Capital raise

Quarterly Earnings (10-Q)

NYSE
ESAB Corporation reported a 9.9% increase in net sales for Q1 2026, driven by acquisitions and favorable foreign exchange, though net income from continuing operations declined due to increased expenses and acquisition-related charges.
Capital raise
Worse than expected
NYSE
ESAB Corporation reports increased net sales and Adjusted EBITDA for Q3 2025, driven by strategic acquisitions, but net income and EPS declined due to higher interest expenses and discontinued operations.
Delay expected
Worse than expected
Capital raise
NYSE
ESAB Corporation reports mixed second-quarter results with sales growth driven by acquisitions, but a decline in net income and organic sales.
Delay expected
Worse than expected
Capital raise
NYSE
ESAB Corporation's first quarter 2025 results show a slight decrease in net sales but an increase in Adjusted EBITDA compared to the same period last year.
NYSE
ESAB Corporation's third-quarter results show a slight decrease in net sales, but improved profitability driven by pricing and cost management, alongside strategic acquisitions.
Better than expected
NYSE
ESAB Corporation's second-quarter results show increased profitability driven by lower costs and favorable product mix, despite a slight decrease in net sales.
Better than expected

Annual Reports (10-K)

NYSE
ESAB Corporation reports increased net sales driven by acquisitions, but faces declining organic sales, lower net income, and increased debt in its 2025 annual filing.
Worse than expected
Capital raise
NYSE
ESAB Corporation's FY2024 results reveal a slight revenue decrease, influenced by strategic acquisitions and unfavorable foreign currency translation, while Adjusted EBITDA and Core adjusted EBITDA margins improve.
Worse than expected
NYSE
ESAB Corporation's 10-K filing details an executive promotion, compensation plans, and a comprehensive list of its subsidiaries.

Insider Trading (Form 4)

NYSE
Ranjana N Bhagwakar, EVP, Business Operations of ESAB Corp, received 15,777 shares of common stock on July 15, 2026.
NYSE
ESAB Corp executive Ranjana N. Bhagwakar reports acquisition of restricted stock units and stock options.
NYSE
ESAB Corp director Robert S. Lutz reported the acquisition of deferred stock units, representing a contingent right to receive shares of common stock.
NYSE
Didier Teirlinck, a Director at ESAB Corp, acquired 134 deferred stock units on June 30, 2026, as a substitute for his director's cash retainer.
NYSE
ESAB Corp CEO Shyam Kambeyanda was granted performance-based stock options for 580,552 shares of common stock.
NYSE
ESAB Corp Chief Human Resources Officer Michele Campion was granted 52,250 performance-based stock options.

Proxy Statements (Def-14A)

NYSE
ESAB Corporation announces its 2026 Annual Meeting of Stockholders, outlining director elections, executive compensation, and corporate governance updates, including a significant capital raise and no cash bonuses for executives in 2025.
Worse than expected
Capital raise
NYSE
ESAB Corporation issues a supplement to its proxy statement clarifying the voting standard for the upcoming 2025 Annual Meeting of Stockholders.
NYSE
ESAB Corporation's 2025 Annual Meeting of Stockholders will be held virtually on May 8, 2025, with proxy materials available online.
NYSE
ESAB Corporation has released its proxy statement outlining proposals for the 2025 Annual Meeting of Stockholders, including director elections, auditor ratification, executive compensation approval, and an incentive plan amendment.
Better than expected
NYSE
ESAB Corporation's 2024 Annual Meeting of Stockholders will be held virtually on May 9, 2024, with proxy materials available online.
NYSE
ESAB Corporation's proxy statement outlines proposals for the upcoming annual meeting, including director elections, ratification of the accounting firm, and an advisory vote on executive compensation.
Better than expected

Schedule 13D - Activist Investments

NYSE
Mitchell P. Rales has increased his beneficial ownership in ESAB Corporation to 7.1% through the acquisition of Series A Mandatory Convertible Preferred Stock and additional common stock contributions.
Capital raise
NYSE
Mitchell P. Rales, a significant beneficial owner, has committed $100 million to ESAB Corporation's new mandatory convertible preferred stock to fund a strategic acquisition.
Capital raise

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has disclosed a beneficial ownership of 5.01% in Esab Corp, holding over 3 million shares.
NYSE
T. Rowe Price Associates, Inc. has reported beneficial ownership of 10.9% of ESAB Corp's common stock as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Esab Corp following an internal realignment that disaggregated reporting responsibilities.
NYSE
T. Rowe Price Associates, Inc. has disclosed a 9.6% beneficial ownership stake in ESAB Corp, holding over 5.8 million shares of common stock.
NYSE
T. Rowe Price Associates, Inc. has reported an 8.6% beneficial ownership stake in ESAB Corp common stock as of September 30, 2025.
NYSE
T. Rowe Price Associates, Inc. has reported an 11.0% beneficial ownership stake in ESAB Corp's common stock, as detailed in an amended Schedule 13G filing.